We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.


Sell:$74.72 Buy:$74.82 Change: $0.78 (1.03%)
Market closed |  Prices as at close on 17 May 2024 | Switch to live prices |
Change: $0.78 (1.03%)
Market closed |  Prices as at close on 17 May 2024 | Switch to live prices |
Change: $0.78 (1.03%)
Market closed |  Prices as at close on 17 May 2024 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

CONMED Corporation is a medical technology company, which provides surgical devices and equipment for minimally invasive procedures. Its products are used by surgeons and other healthcare professionals in a variety of specialties including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. Its product lines consist of orthopedic surgery and general surgery. Orthopedic surgery consists of sports medicine and lower extremities instrumentation and implants, small bone, large bone, and specialty powered surgical instruments as well as imaging systems for use in minimally invasive surgery procedures and fees related to the sales representation, promotion, and marketing of sports medicine allograft tissue. General surgery consists of endo-mechanical instrumentation for minimally invasive laparoscopic and gastrointestinal procedures, smoke evacuation devices, a line of cardiac monitoring products as well as electrosurgical generators and related instruments.

Contact details

11311 Concept Boulevard
United States
+1 (727) 2142974

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
$2.30 billion
Shares in issue:
30.80 million
Health Care Equipment
New York Stock Exchange
United States
US dollar

Key personnel

  • Curt Hartman
    Chairman of the Board, President, Chief Executive Officer
  • Todd Garner
    Chief Financial Officer, Executive Vice President - Finance
  • Patrick Beyer
    Chief Operating Officer
  • Heather Cohen
    Executive Vice President, Chief Human Resource and Legal Officer
  • Shanna Cotti-osmanski
    Executive Vice President, Information Technology and Chief Information Officer
  • John Ferrell
    Executive Vice President, Human Resources
  • Peter Shagory
    Executive Vice President - Strategy and Corporate Development
  • Stanley Peters
    Vice President and General Manager - U.S. Advanced Surgical
  • Terence Berge
    Vice President and Corporate Controller
  • Johonna Pelletier
    Treasurer and Vice President - Tax

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.